Page last updated: 2024-09-03

tazobactam and Bacterial Disease

tazobactam has been researched along with Bacterial Disease in 88 studies

Research

Studies (88)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (3.41)	18.7374
1990's	42 (47.73)	18.2507
2000's	21 (23.86)	29.6817
2010's	19 (21.59)	24.3611
2020's	3 (3.41)	2.80

Authors

Authors	Studies
Colchón, E; González-Bello, C; Pernas, M; Rodríguez, Á; Rodríguez, D	1
Benvenuti, M; Burns, CJ; Chu, GH; Cusick, SM; Daigle, DM; De Luca, F; Docquier, JD; Hamrick, JC; Jackson, RW; Liu, B; Mangani, S; McGarry, D; Pevear, DC; Pozzi, C; Trout, REL; Weiss, WJ; Xerri, L	1
Baillon-Plot, N; Bassetti, M; Charbonneau, C; Di Virgilio, R; Eckmann, C; Kongnakorn, T; Tichy, E	1
Cardoso, MH; Costa, BO; Franco, OL	1
Rademacher, J; Welte, T	1
Carlier, M; De Cock, PAJG; de Jaeger, A; De Paepe, P; Delanghe, JR; Della Pasqua, OE; Robays, H; van Dijkman, SC; Vande Walle, J; Verstraete, AG; Willems, J	1
Huntington, JA; Long, J; Popejoy, MW	1
Chiu, S; Ferguson, JK; Kozierowski, K; Munnoch, SA; Oldmeadow, C	1
Cabri, W; Cerisoli, L; Ferrazzano, L; Martelli, G; Ricci, A; Tolomelli, A; Viola, A	1
Brock, B; Friberg, LE; Kristoffersson, AN; Maarbjerg, SF; Nielsen, EI; Schrøder, H; Thorsted, A; Wang, M	1
Charoenpong, L; Thamlikitkul, V; Tongsai, S	1
Chhibba, A; Nayak, U; Patankar, M; Sequeira, L; Sukumaran, S	1
Chandorkar, G; Hershberger, E; Krishna, G; Mouksassi, MS; Xiao, A	1
Agudelo, M; Rodriguez, CA; Vesga, O; Zuluaga, AF	1
Chen, L; Wang, Y; Yang, H; Zhang, C; Zhou, Q	1
Barie, PS; Collins, S; Eckmann, C; Friedland, I; Hershberger, E; Miller, B; Popejoy, M; Solomkin, J; Steenbergen, J; Yoon, M; Yuan, G	1
Connor, KA	1
Bleeker-Rovers, CP; Koopman, M; Mannaerts, L; Punt, CJ; van Herpen, CM	1
An, MM; Chen, ML; Jiang, YY; Liu, P; Shen, H; Wang, R; Zhang, JD; Zou, Z	1
Blondiaux, N; Courcol, RJ; Durocher, A; Favory, R; Nseir, S; Onimus, T; Roussel-Delvallez, M; Wallet, F	1
Holzgrabe, U	1
Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ	1
Beumier, M; Cotton, F; De Backer, D; Hites, M; Jacobs, F; Lorent, S; Roisin, S; Seyler, L; Surin, R; Taccone, FS; Vincent, JL; Wolff, F	1
Alder, J; Arvis, P; Dryden, M; Gyssens, IC; Kujath, P; Nathwani, D; Reimnitz, P; Schaper, NC	1
Berardi, B; Callea, A; Cormio, L; Fiorentino, N; Sblendorio, D; Traficante, A; Zizzi, V	1
Bornhauser, M; Ehninger, G; Hanel, M; Kroschinsky, F; Ordemann, R; Schuler, U; Wichmann, G	1
Bethe, U; Breuer, K; Cornely, OA; Diehl, V; Fätkenheuer, G; Karthaus, M; Reichert, D; Salzberger, B; Schwonzen, M; Seifert, H; Ullmann, AJ; Wicke, T	1
Kwan, TH; Siu, YP; Tong, MK; Yung, CY	1
Dana, A; Kuti, JL; Li, C; Mansfield, DL; Nicolau, DP; Nightingale, CH	1
Jacobus, NV; Kuck, NA; Petersen, PJ; Tally, FP; Testa, RT; Weiss, WJ	1
Dana, A; DeRyke, CA; Kuti, JL; Mansfield, D; Nicolau, DP	1
Bhattacharya, SK; Kumari, N; Mohapatra, TM; Rai, A	1
Dana, A; Itani, KM; Kuti, JL; Lau, WK; Mansfield, D; Mercer, D; Nicolau, DP	1
Burgess, DS; Frei, CR; Hampton, SL	1
Antretter, H; Bonatti, H; Guggenbichler, JP; Ladurner, R; Laesser, R; Margreiter, R; Mark, W; Muehlmann, G; Stelzmueller, I; Tabarelli, D; Tabarelli, W; Wiesmayr, S; Zimmerhackl, LB	1
Cross, SE; Dalley, AJ; Lipman, J; Roberts, MS; Rudd, M; Venkatesh, B	1
Choudhri, S; Giordano, P; Lipsky, BA; Song, J	1
Brogden, RN; Bryson, HM	1
Aldridge, KE	1
Kinzig, M; Sörgel, F	1
Lahnborg, G; Nord, CE	1
File, TM; Tan, JS	2
Grundel, E; Vestweber, KH	1
Brewster, SF; Gingell, JC; MacGowan, AP	1
Dudley, MN	1
Jones, RN	1
Danziger, LH; Occhipinti, DJ; Rodvold, KA; Schoonover, LL	1
Fujii, R; Fujita, K; Fukushima, N; Inyaku, F; Ishikawa, A; Okuno, A; Saijo, M; Takimoto, M; Wagatsuma, S; Yoshikawa, M	1
Gorbach, SL	1
Nord, CE	1
Nowé, P	1
Bywater, MJ; Holt, HA; MacGowan, AP; Reeves, DS	1
Faro, S; O'Brien, WF; Roy, S; Sanfilippo, JS; Seidlin, M; Sweet, RL	1
Alhava, E; Haapiainen, R; Havia, T; Kivilaakso, E; Laitinen, S; Matikainen, M; Miettinen, P; Niinikoski, J; Pääkkönen, M	1
Cullmann, W; Elhardt, D; Tassler, H	1
Acar, JF; Goldstein, FW; Kitzis, MD	1
DeVries, VG; Kuye, O; Morrow, CA; Tally, FP; Teal, J	1
Eklund, AE; Nord, CE	1
Gentile, G; Girmenia, C; Martino, P; Meloni, G; Micozzi, A; Nucci, M; Venditti, M	1
Gupte, JM; Immermann, FW; Jacobus, NV; Testa, RT	1
Barie, PS; Cheadle, WG; Fink, MP; Garber, GE; Hebert, JC; Laverdiere, M; Polk, HC; Wilson, SE	1
Bourget, P; Carsin, H; Le Bever, H; Le Reveillé, R; Lesne-Hulin, A	1
Blumer, JL; Bonafede, ME	1
Chimura, T; Hirayama, T	1
Higashitani, F; Hyodo, A; Kunugita, C; Nishida, K; Unemi, N	1
Dudley, MN; Okereke, C	1
Bryce, EA; Frighetto, LO; Jewesson, PJ; Marra, CA; Marra, FO; Reynolds, RP; Sleigh, KM; Stiver, HG	1
Baudard, M; Bouvet, A; Chast, F; Delmer, A; Legrand, O; Levy, V; Marie, JP; Marjanovic, Z; Rio, B; Vekhoff, A; Zittoun, R	1
Caballero, D; Encinas, MP; García-Sanz, R; Gutiérrez, N; Hurlé, AD; Morín, LS; Vázquez, L; Vilches, P	1
Markham, A; Perry, CM	1
Cederberg, A; Forssell, H; Ohlin, B; Solhaug, JH; Tveit, E	1
Christou, N; Eiseman, I; Siami, G; Tack, KJ	1
Niki, Y	1
Hidai, H	1
Mealey, KL	1
Bode, U; Fleischhack, G; Hasan, C; Havers, W; Marklein, G; Schmidt-Niemann, M; Wulff, B	1
Androulakakis, E; Dimitriou, L; Kafetzis, DA; Lebesii, E; Maltezou, HC; Nikolaidis, P	1
Liu, Y; Wang, R; Yu, B	1
Spencer, RC; Wilcox, MH; Winstanley, TG	1
Brismar, B; Kasholm-Tengve, B; Nord, CE; Tunevall, G	1
Kelsey, SM; Newland, AC; Pocock, CE; Shaw, E; Weinhardt, B	1
Bäckstrand, B; Bergman, L; Brismar, B; Kihlström, E; Malmborg, AS; Mentzing, LO; Nyström, PO; Skau, T; Tunevall, G; Wretlind, B	1
Ansari, A; Douglas, JG; Gould, IM; Harvey, G; Reid, TM; Smith, CC	1
Jacobus, NV; Kuck, NA; Petersen, PJ; Testa, RT; Weiss, WJ	1
Aronoff, SC; Jacobs, MR; Labrozzi, PH; Yamabe, S	1

Reviews

23 review(s) available for tazobactam and Bacterial Disease

Article	Year
β-Lactamase Inhibitors To Restore the Efficacy of Antibiotics against Superbugs. Journal of medicinal chemistry, 2020, 03-12, Volume: 63, Issue:5 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Humans; Protein Structure, Secondary; Protein Structure, Tertiary; Treatment Outcome	2020
Development of Peptides that Inhibit Aminoglycoside-Modifying Enzymes and β-Lactamases for Control of Resistant Bacteria. Current protein & peptide science, 2020, Volume: 21, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Infections; beta-Lactamases; beta-Lactams; Clavulanic Acid; Drug Design; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin Kinase; Nucleotidyltransferases; Sulbactam; Tazobactam	2020
[New antibiotics - standstill or progress]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2017, Volume: 112, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ephedrine; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Penicillanic Acid; Phenobarbital; Staphylococcal Infections; Tazobactam; Theophylline; Triazoles	2017
Clinical outcomes with alternative dosing strategies for piperacillin/tazobactam: a systematic review and meta-analysis. PloS one, 2015, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Databases, Factual; Humans; Odds Ratio; Penicillanic Acid; Piperacillin; Renal Insufficiency; Tachycardia; Tazobactam	2015
Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials. BMC infectious diseases, 2009, Dec-02, Volume: 9 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam; Treatment Outcome	2009
Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:2 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; Carbapenems; Drug Administration Schedule; Humans; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome	2013
Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs, 1994, Volume: 47, Issue:3 Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Randomized Controlled Trials as Topic; Tazobactam	1994
Anaerobes in polymicrobial surgical infections: incidence, pathogenicity, and antimicrobial resistance. The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573 Topics: Abdominal Abscess; Bacteremia; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Incidence; Penicillanic Acid; Peritonitis; Piperacillin; Surgical Wound Infection; Tazobactam; Virulence	1994
Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections. The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573 Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Injections, Intramuscular; Injections, Intravenous; Metabolic Clearance Rate; Penicillanic Acid; Piperacillin; Soft Tissue Infections; Tazobactam; Tissue Distribution	1994
Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections. The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573 Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases, Bacterial; Soft Tissue Infections; Tazobactam; Ticarcillin	1994
Combination beta-lactam and beta-lactamase-inhibitor therapy: pharmacokinetic and pharmacodynamic considerations. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Mar-15, Volume: 52, Issue:6 Suppl 2 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	1995
Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Mar-15, Volume: 52, Issue:6 Suppl 2 Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Soft Tissue Infections; Tazobactam	1995
Piperacillin/tazobactam: a new beta-lactam/beta-lactamase inhibitor combination. The Annals of pharmacotherapy, 1995, Volume: 29, Issue:5 Topics: Bacterial Infections; beta-Lactamase Inhibitors; Child; Child, Preschool; Clinical Trials as Topic; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam	1995
Treatment of skin and soft-tissue infections. American journal of surgery, 1995, Volume: 169, Issue:5A Suppl Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Fasciitis; Humans; Necrosis; Penicillanic Acid; Piperacillin; Skin Diseases; Soft Tissue Infections; Surgical Wound Infection; Tazobactam	1995
Piperacillin/tazobactam in the treatment of polymicrobial infections. Intensive care medicine, 1994, Volume: 20 Suppl 3 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Drug Combinations; Drug Resistance, Microbial; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam	1994
The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam. Intensive care medicine, 1994, Volume: 20 Suppl 3 Topics: Abdomen; Bacterial Infections; beta-Lactamase Inhibitors; Clinical Trials as Topic; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam	1994
Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children. Advances in pediatric infectious diseases, 1996, Volume: 12 Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Carbapenems; Cephalosporins; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Fluoroquinolones; Humans; Molecular Structure; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Ticarcillin	1996
[Development of beta-lactamase inhibitors]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:5 Topics: Animals; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Drug Therapy, Combination; Mice; Penicillanic Acid; Piperacillin; Tazobactam	1997
Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host. The Journal of antimicrobial chemotherapy, 1998, Volume: 41 Suppl D Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; Drug Therapy, Combination; Humans; Models, Biological; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam	1998
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections. Drugs, 1999, Volume: 57, Issue:5 Topics: Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam	1999
[Fundamental and clinical studies on beta-lactamase inhibitors]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:4 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam	2001
[Antibiotics--TAZ/PIPC, synercid, linezolid, everninomicin]. Nihon rinsho. Japanese journal of clinical medicine, 2001, Volume: 59, Issue:4 Topics: Acetamides; Adult; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Drug Combinations; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Linezolid; Oxazolidinones; Penicillanic Acid; Penicillins; Piperacillin; Protein Synthesis Inhibitors; Tazobactam; Virginiamycin	2001
Penicillins and beta-lactamase inhibitor combinations. Journal of the American Veterinary Medical Association, 2001, Jun-15, Volume: 218, Issue:12 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Penicillanic Acid; Penicillins; Sulbactam; Tazobactam	2001

Trials

34 trial(s) available for tazobactam and Bacterial Disease

Article	Year
Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam. BMC infectious diseases, 2017, 05-02, Volume: 17, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Female; Humans; Intraabdominal Infections; Levofloxacin; Male; Metronidazole; Middle Aged; Penicillanic Acid; Pyelonephritis; Tazobactam; Urinary Tract Infections	2017
Population pharmacokinetics of ceftolozane/tazobactam in healthy volunteers, subjects with varying degrees of renal function and patients with bacterial infections. Journal of clinical pharmacology, 2015, Volume: 55, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Female; Healthy Volunteers; Humans; Male; Middle Aged; Models, Biological; Penicillanic Acid; Renal Insufficiency; Tazobactam; Young Adult	2015
Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, May-15, Volume: 60, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cephalosporins; Double-Blind Method; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intraabdominal Infections; Male; Metronidazole; Middle Aged; Penicillanic Acid; Prospective Studies; Tazobactam; Treatment Outcome; Young Adult	2015
Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study. Infection, 2013, Volume: 41, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacterial Infections; Diabetic Foot; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam; Treatment Outcome	2013
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU international, 2002, Volume: 90, Issue:7 Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Ciprofloxacin; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Injections, Intramuscular; Male; Penicillanic Acid; Penicillins; Piperacillin; Postoperative Complications; Prospective Studies; Prostatic Diseases; Tazobactam; Transurethral Resection of Prostate	2002
Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia. International journal of hematology, 2004, Volume: 79, Issue:1 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Bacterial Infections; Disease Susceptibility; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Fever of Unknown Origin; Humans; Immunocompromised Host; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Treatment Outcome	2004
Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:2 Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam	2005
Pharmacoeconomics of continuous versus intermittent infusion of piperacillin-tazobactam for the treatment of complicated intraabdominal infection. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Apr-15, Volume: 63, Issue:8 Topics: Abdomen; Adult; Bacterial Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam	2006
Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11 Topics: Abdomen; Adolescent; Adult; Aged; APACHE; Bacterial Infections; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Penicillins; Tazobactam	2006
Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2 Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Databases, Factual; Diabetic Foot; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Penicillanic Acid; Piperacillin; Quinolines; Tazobactam	2007
Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections. The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573 Topics: Abdomen; Abdominal Abscess; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Europe; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam	1994
Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group. The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573 Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Female; Gentamicins; Humans; Kidney; Kidney Function Tests; Male; Middle Aged; North America; Penicillanic Acid; Piperacillin; Tazobactam	1994
Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. British journal of urology, 1995, Volume: 76, Issue:3 Topics: Aged; Bacterial Infections; beta-Lactamases; Biopsy, Needle; Cefuroxime; Drug Therapy, Combination; Humans; Injections, Intravenous; Male; Penicillanic Acid; Piperacillin; Prospective Studies; Prostate; Prostatic Neoplasms; Tazobactam	1995
[Comprehensive evaluation of pharmacokinetic and clinical studies on tazobactam/piperacillin in pediatric field]. The Japanese journal of antibiotics, 1995, Volume: 48, Issue:3 Topics: Adolescent; Bacteria; Bacterial Infections; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Penicillanic Acid; Piperacillin; Tazobactam	1995
Piperacillin/tazobactam in complicated urinary tract infections. Intensive care medicine, 1994, Volume: 20 Suppl 3 Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Recurrence; Remission Induction; Tazobactam; Urinary Tract Infections	1994
Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group. Obstetrics and gynecology, 1994, Volume: 83, Issue:2 Topics: Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Administration Schedule; Drug Therapy, Combination; Endometritis; Female; Gentamicins; Humans; Pelvic Inflammatory Disease; Penicillanic Acid; Piperacillin; Tazobactam	1994
Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections. Surgery, gynecology & obstetrics, 1993, Volume: 176, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Male; Middle Aged; Penicillanic Acid; Peritoneal Diseases; Piperacillin; Tazobactam; Treatment Outcome	1993
Safety profile of piperacillin/tazobactam in phase I and III clinical studies. The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Penicillanic Acid; Piperacillin; Tazobactam	1993
A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group. The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam	1993
Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:1 Topics: Adolescent; Adult; Aged; Amikacin; Bacteremia; Bacteria; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam; Teicoplanin	1993
Susceptibility of anaerobes in phase 3 clinical studies of piperacillin/tazobactam. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 16 Suppl 4 Topics: Bacteria, Anaerobic; Bacterial Infections; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	1993
Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The Piperacillin/Tazobactam Intra-Abdominal Infection Study Group. The American surgeon, 1993, Volume: 59, Issue:9 Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cholangitis; Cholecystitis; Clindamycin; Combined Modality Therapy; Diverticulitis; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam	1993
Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:1 Topics: Adult; Bacterial Infections; beta-Lactamase Inhibitors; Burns; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam	1996
[Clinical study of tazobactam/piperacillin in obstetrics and gynecological infections]. The Japanese journal of antibiotics, 1996, Volume: 49, Issue:8 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Infusions, Intravenous; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam	1996
Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective. The Annals of pharmacotherapy, 1999, Volume: 33, Issue:2 Topics: Adult; Anti-Infective Agents; Bacterial Infections; British Columbia; Cilastatin; Costs and Cost Analysis; Decision Trees; Double-Blind Method; Drug Therapy, Combination; Economics, Pharmaceutical; Enzyme Inhibitors; Female; Humans; Imipenem; Male; Models, Economic; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Protease Inhibitors; Statistics, Nonparametric; Tazobactam; Thienamycins; Treatment Outcome	1999
Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1999, Volume: 7, Issue:2 Topics: Adult; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Bacterial Infections; Case-Control Studies; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Tazobactam; Tobramycin; Vancomycin	1999
Randomized prospective study comparing cost-effectiveness of teicoplanin and vancomycin as second-line empiric therapy for infection in neutropenic patients. Haematologica, 1999, Volume: 84, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Blood Chemical Analysis; Cost-Benefit Analysis; Drug Costs; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Safety; Tazobactam; Teicoplanin; Treatment Failure; Vancomycin	1999
Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections. The European journal of surgery = Acta chirurgica, 1999, Volume: 165, Issue:9 Topics: Abdominal Abscess; Appendicitis; Bacterial Infections; beta-Lactamase Inhibitors; Cefuroxime; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Intestinal Perforation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Rupture, Spontaneous; Surgical Wound Infection; Tazobactam	1999
Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fluoroquinolones; Humans; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Skin Diseases, Infectious; Tazobactam	2001
Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2001, Volume: 9, Issue:5 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Drug Therapy, Combination; Enzyme Inhibitors; Fever; Gentamicins; Germany; Humans; Neoplasms; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Sulbactam; Tazobactam; Treatment Outcome	2001
Piperacillin/Tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2001, Volume: 20, Issue:9 Topics: Abdominal Abscess; Adolescent; Appendicitis; Bacterial Infections; Cefotaxime; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Perforation; Male; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome	2001
[Multicentre clinical trial on efficacy and safety of domestic piperacillin/tazobactam for treatment of acute bacterial infections]. Zhonghua yi xue za zhi, 2001, Jan-10, Volume: 81, Issue:1 Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Drug Therapy, Combination; Humans; Middle Aged; Penicillanic Acid; Piperacillin; Skin Diseases; Tazobactam; Treatment Outcome	2001
Piperacillin/tazobactam plus gentamicin as empirical therapy for febrile neutropenic patients with haematological malignancy. Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bacterial Infections; beta-Lactamase Inhibitors; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam	1992
Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12 Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome	1992

Other Studies

31 other study(ies) available for tazobactam and Bacterial Disease

Article	Year
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections. Journal of medicinal chemistry, 2020, 03-26, Volume: 63, Issue:6 Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamase Inhibitors; Borinic Acids; Carbapenems; Carboxylic Acids; Humans; Mice; Models, Molecular	2020
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI). Antimicrobial resistance and infection control, 2019, Volume: 8 Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftazidime; Cephalosporins; Cost-Benefit Analysis; Drug Combinations; Hospitalization; Humans; Intraabdominal Infections; Italy; Meropenem; Models, Economic; Tazobactam	2019
Dose optimization of piperacillin/tazobactam in critically ill children. The Journal of antimicrobial chemotherapy, 2017, 07-01, Volume: 72, Issue:7 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Tazobactam	2017
Reduced VRE and MRSA colonisation and infection following sustained reduction in broad spectrum antibiotic use in a large tertiary hospital. The Medical journal of Australia, 2019, Volume: 211, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Utilization Review; Humans; Methicillin-Resistant Staphylococcus aureus; New South Wales; Piperacillin; Tazobactam; Vancomycin-Resistant Enterococci	2019
Novel insights into the chemistry of an old medicine: A general degradative pathway for penicillins from a piperacillin/tazobactam stability study. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019, Aug-01, Volume: 136 Topics: Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam	2019
Population pharmacokinetics of piperacillin in febrile children receiving cancer chemotherapy: the impact of body weight and target on an optimal dosing regimen. The Journal of antimicrobial chemotherapy, 2019, 10-01, Volume: 74, Issue:10 Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Body Weight; Child; Child, Preschool; Female; Fever; Glomerular Filtration Rate; Humans; Infant; Male; Microbial Sensitivity Tests; Neoplasms; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam	2019
Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-P) for treatment of infected patients at Siriraj Hospital. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2013, Volume: 96 Suppl 2 Topics: Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Child; Drugs, Generic; Female; Hospitals; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thailand; Young Adult	2013
Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections. The Journal of the Association of Physicians of India, 2012, Volume: 60 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporin Resistance; Disk Diffusion Antimicrobial Tests; Drug Combinations; Humans; India; Penicillanic Acid; Respiratory Tract Infections; Sulbactam; Tazobactam; Urinary Tract Infections	2012
Relevance of various animal models of human infections to establish therapeutic equivalence of a generic product of piperacillin/tazobactam. International journal of antimicrobial agents, 2015, Volume: 45, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Disease Models, Animal; Enterobacter cloacae; Humans; Mesothelin; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam	2015
Newer Intravenous Antibiotics in the Intensive Care Unit: Ceftaroline, Ceftolozane-Tazobactam, and Ceftazidime-Avibactam. AACN advanced critical care, 2016, Volume: 27, Issue:4 Topics: Administration, Intravenous; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Combinations; Education, Medical, Continuing; Humans; Intensive Care Units; Penicillanic Acid; Tazobactam; United States	2016
Pylephlebitis after a duodenal ulcer in a patient with metastasised colon carcinoma treated with chemotherapy and bevacizumab: a case report. The Netherlands journal of medicine, 2009, Volume: 67, Issue:2 Topics: Aged; Amoxicillin; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bacterial Infections; Bevacizumab; Clavulanic Acid; Colorectal Neoplasms; Duodenal Ulcer; Humans; Male; Penicillanic Acid; Piperacillin; Portal Vein; Tazobactam; Thrombophlebitis	2009
Daily serum piperacillin monitoring is advisable in critically ill patients. International journal of antimicrobial agents, 2010, Volume: 35, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Critical Illness; Drug Monitoring; Female; France; Hospitals, Teaching; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prospective Studies; Serum; Tazobactam; Time Factors	2010
[Inhibitors of the New Delhi-Metallolactamase]. Pharmazie in unserer Zeit, 2012, Volume: 41, Issue:4 Topics: Bacterial Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cell Membrane; Clavulanic Acid; Drug Resistance, Bacterial; Drug Resistance, Microbial; Enzyme Inhibitors; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Penicillanic Acid; Tazobactam	2012
Case-control study of drug monitoring of β-lactams in obese critically ill patients. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Case-Control Studies; Cefepime; Ceftazidime; Cephalosporins; Drug Monitoring; Enzyme Inhibitors; Female; Humans; Male; Meropenem; Middle Aged; Obesity; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Renal Replacement Therapy; Sepsis; Shock, Septic; Tazobactam; Thienamycins; Young Adult	2013
Efficacy and tolerability of prophylactic treatment with intravenous piperacillin/tazobactam in patients undergoing hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2002, Volume: 4, Issue:3 Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bacterial Infections; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Penicillanic Acid; Pilot Projects; Piperacillin; Tazobactam; Transplantation, Autologous; Transplantation, Homologous	2002
Piperacillin/tazobactam-induced acute delirium in a peritoneal dialysis patient. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, Volume: 19, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; Confusion; Delirium; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Hallucinations; Humans; Kidney Failure, Chronic; Male; Middle Aged; Penicillanic Acid; Peritoneal Dialysis, Continuous Ambulatory; Piperacillin; Tazobactam	2004
Synergistic activity of piperacillin: YTR-830H combinations in vitro and in vivo. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Gastric Juice; Hydrogen-Ion Concentration; Mice; Microbial Sensitivity Tests; Mucins; Penicillanic Acid; Piperacillin; Swine; Tazobactam	1989
In-vitro evaluation of "piperacillin and tazobactum" combination in a tertiary-care hospital--a preliminary study. Indian journal of pathology & microbiology, 2006, Volume: 49, Issue:1 Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Hospitals; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	2006
Influence of culture site-specific MIC distributions on the pharmacokinetic and pharmacodynamic properties of piperacillin/tazobactam and piperacillin: a data analysis. Clinical therapeutics, 2006, Volume: 28, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; Data Interpretation, Statistical; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam	2006
Experience with the use of piperacillin-tazobactam in pediatric non-renal solid organ transplantation. Pediatric transplantation, 2007, Volume: 11, Issue:1 Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Mycoses; Organ Transplantation; Penicillanic Acid; Piperacillin; Tazobactam	2007
Inadequate antimicrobial prophylaxis during surgery: a study of beta-lactam levels during burn debridement. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; beta-Lactams; Burns; Cephalothin; Debridement; Drug Administration Schedule; Drug Therapy, Combination; Humans; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam	2007
Efficacy of piperacillin/tazobactam in the treatment of experimental intra-abdominal infections. The European journal of surgery. Supplement. : = Acta chirurgica. Supplement, 1994, Issue:573 Topics: Abdomen; Animals; Bacterial Infections; beta-Lactamase Inhibitors; Clindamycin; Drug Therapy, Combination; Gentamicins; Imipenem; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Rats; Rats, Sprague-Dawley; Tazobactam	1994
[Drugs: piperacillin/tazobactam]. Enfermedades infecciosas y microbiologia clinica, 1995, Volume: 13, Issue:2 Topics: Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Humans; Penicillanic Acid; Piperacillin; Tazobactam	1995
The activity of piperacillin/tazobactam against clinical isolates collected in 20 UK centres and the design of a disc test for susceptibility testing. The Journal of antimicrobial chemotherapy, 1993, Volume: 32, Issue:1 Topics: Bacteria, Aerobic; Bacterial Infections; beta-Lactamase Inhibitors; Culture Media; Diffusion; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam; United Kingdom	1993
Therapy of soft tissue infections with piperacillin/tazobactam. The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Risk Factors; Skin Diseases, Infectious; Tazobactam	1993
Susceptibility survey of piperacillin alone and in the presence of tazobactam. The Journal of antimicrobial chemotherapy, 1993, Volume: 31 Suppl A Topics: Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	1993
Effect of pH on antibiotics used to treat anaerobic infection. The Journal of antimicrobial chemotherapy, 1992, Volume: 29, Issue:5 Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cefoxitin; Clindamycin; Drug Therapy, Combination; Hydrogen-Ion Concentration; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	1992
Effect of piperacillin/tazobactam therapy on intestinal microflora. Scandinavian journal of infectious diseases, 1992, Volume: 24, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Feces; Female; Humans; Intestines; Male; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Yeasts	1992
Piperacillin/tazobactam in the treatment of serious acute soft tissue infection. Drugs under experimental and clinical research, 1991, Volume: 17, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; beta-Lactamase Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam	1991
Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam. Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:11 Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam	1989
Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in mice. The Journal of antimicrobial chemotherapy, 1986, Volume: 18, Issue:2 Topics: Amoxicillin; Animals; Bacterial Infections; Citrobacter; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Mice; Penicillanic Acid; Proteus Infections; Staphylococcal Infections; Tazobactam	1986